A citation-based method for searching scientific literature


List of co-cited articles
849 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
62

Ivabradine in stable coronary artery disease without clinical heart failure.
Kim Fox, Ian Ford, Philippe Gabriel Steg, Jean-Claude Tardif, Michal Tendera, Roberto Ferrari. N Engl J Med 2014
285
43

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
33



Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
18

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Jean-Claude Tardif, Ian Ford, Michal Tendera, Martial G Bourassa, Kim Fox. Eur Heart J 2005
339
17

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, Felicita Andreotti, Chris Arden, Andrzej Budaj, Raffaele Bugiardini, Filippo Crea, Thomas Cuisset, Carlo Di Mario,[...]. Eur Heart J 2013
17

Eplerenone in patients with systolic heart failure and mild symptoms.
Faiez Zannad, John J V McMurray, Henry Krum, Dirk J van Veldhuisen, Karl Swedberg, Harry Shi, John Vincent, Stuart J Pocock, Bertram Pitt. N Engl J Med 2011
17

The Clinical Use of Ivabradine.
Jacob S Koruth, Anuradha Lala, Sean Pinney, Vivek Y Reddy, Srinivas R Dukkipati. J Am Coll Cardiol 2017
55
27

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
Michael Böhm, Karl Swedberg, Michel Komajda, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
603
14



Effect of carvedilol on survival in severe chronic heart failure.
M Packer, A J Coats, M B Fowler, H A Katus, H Krum, P Mohacsi, J L Rouleau, M Tendera, A Castaigne, E B Roecker,[...]. N Engl J Med 2001
13

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
Salim Yusuf, Bertram Pitt, Clarence E Davis, William B Hood, Jay N Cohn. N Engl J Med 1991
13

Heart rate and cardiovascular mortality: the Framingham Study.
W B Kannel, C Kannel, R S Paffenbarger, L A Cupples. Am Heart J 1987
943
12

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset,[...]. Eur Heart J 2020
12




The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
M Packer, M R Bristow, J N Cohn, W S Colucci, M B Fowler, E M Gilbert, N H Shusterman. N Engl J Med 1996
11



Expert consensus document: A 'diamond' approach to personalized treatment of angina.
Roberto Ferrari, Paolo G Camici, Filippo Crea, Nicolas Danchin, Kim Fox, Aldo P Maggioni, Athanasios J Manolis, Mario Marzilli, Giuseppe M C Rosano, José L Lopez-Sendon. Nat Rev Cardiol 2018
66
15


Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Anne L Taylor, Susan Ziesche, Clyde Yancy, Peter Carson, Ralph D'Agostino, Keith Ferdinand, Malcolm Taylor, Kirkwood Adams, Michael Sabolinski, Manuel Worcel,[...]. N Engl J Med 2004
10

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. J Am Coll Cardiol 2017
10


Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Bertram Pitt, Willem Remme, Faiez Zannad, James Neaton, Felipe Martinez, Barbara Roniker, Richard Bittman, Steve Hurley, Jay Kleiman, Marjorie Gatlin. N Engl J Med 2003
10

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
9

Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Michel Komajda, Richard Isnard, Alain Cohen-Solal, Marco Metra, Burkert Pieske, Piotr Ponikowski, Adriaan A Voors, Fabienne Dominjon, Cécile Henon-Goburdhun, Matthieu Pannaux,[...]. Eur J Heart Fail 2017
106
9

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Jean-Claude Tardif, Eileen O'Meara, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
204
9

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
539
9

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. J Am Coll Cardiol 2013
9


Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Christopher B Granger, John J V McMurray, Salim Yusuf, Peter Held, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Marc A Pfeffer, Karl Swedberg. Lancet 2003
9

Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
Francisco J Hidalgo, Manuel Anguita, Juan C Castillo, Sara Rodríguez, Laura Pardo, Enrique Durán, José J Sánchez, Carlos Ferreiro, Manuel Pan, Dolores Mesa,[...]. Int J Cardiol 2016
52
15


Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.
Finlay A McAlister, Natasha Wiebe, Justin A Ezekowitz, Alexander A Leung, Paul W Armstrong. Ann Intern Med 2009
350
8

Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
31
25

β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Sripal Bangalore, Gabriel Steg, Prakash Deedwania, Kevin Crowley, Kim A Eagle, Shinya Goto, E Magnus Ohman, Christopher P Cannon, Sidney C Smith, Uwe Zeymer,[...]. JAMA 2012
286
8

Resting heart rate in cardiovascular disease.
Kim Fox, Jeffrey S Borer, A John Camm, Nicolas Danchin, Roberto Ferrari, Jose L Lopez Sendon, Philippe Gabriel Steg, Jean-Claude Tardif, Luigi Tavazzi, Michal Tendera. J Am Coll Cardiol 2007
652
8

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Ruairidh I R Martin, Oksana Pogoryelova, Mauro Santibáñez Koref, John P Bourke, M Dawn Teare, Bernard D Keavney. Heart 2014
94
8

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
8

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.
Milton Packer, Michael B Fowler, Ellen B Roecker, Andrew J S Coats, Hugo A Katus, Henry Krum, Paul Mohacsi, Jean L Rouleau, Michal Tendera, Christoph Staiger,[...]. Circulation 2002
793
8

Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
Michael Böhm, Jeffrey S Borer, John Camm, Ian Ford, Suzanne M Lloyd, Michel Komajda, Luigi Tavazzi, Mario Talajic, Mitja Lainscak, Jan-Christian Reil,[...]. Eur J Heart Fail 2015
44
15


Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Michael Böhm, Jeffrey Borer, Ian Ford, Jose R Gonzalez-Juanatey, Michel Komajda, Jose Lopez-Sendon, Jan-Christian Reil, Karl Swedberg, Luigi Tavazzi. Clin Res Cardiol 2013
144
7

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
Inger Ekman, Olivier Chassany, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Luigi Tavazzi, Karl Swedberg. Eur Heart J 2011
139
7

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Giora Weisz, Philippe Généreux, Andres Iñiguez, Aleksander Zurakowski, Michael Shechter, Karen P Alexander, Ovidiu Dressler, Anna Osmukhina, Stefan James, E Magnus Ohman,[...]. Lancet 2016
72
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.